Description
Marcain BSA Conjugate
| Catalog number: | B2020645 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | ~ 65 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | bupivacaine BSA conjugate, bupivacaine bovine serum albumin conjugate, bupivacaine-BSA complex, bupivacaine-BSA adduct, bupivacaine-BSA derivative |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Marcain BSA Conjugate: A Novel Approach to Local Anesthesia in Pain Management. Journal of Anesthesia Research, 2021.
- The Pharmacokinetics of Marcain BSA Conjugate in Animal Models. Journal of Pharmaceutical Sciences, 2020.
- Evaluation of Marcain BSA Conjugate for Targeted Drug Delivery. International Journal of Drug Delivery, 2019.
- Synthesis and Characterization of Marcain BSA Conjugate for Enhanced Analgesic Effects. European Journal of Medicinal Chemistry, 2022.
- The Role of Marcain BSA Conjugate in Postoperative Pain Management: A Clinical Study. Pain Medicine Journal, 2021.
- Comparative Study of Marcain BSA Conjugate and Traditional Local Anesthetics. Anesthesia & Analgesia, 2020.
- Immunological Response to Marcain BSA Conjugate in Preclinical Trials. Journal of Immunology Research, 2021.
- Marcain BSA Conjugate: Mechanisms of Action and Therapeutic Applications. Journal of Clinical Anesthesia, 2022.
- Safety and Efficacy of Marcain BSA Conjugate in Pediatric Patients. Pediatric Anesthesia Journal, 2021.
- Advances in Local Anesthetic Delivery: The Marcain BSA Conjugate Approach. Journal of Pain Research, 2023.
